Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study
Background: Hereditary angioedema (HAE) is a genetic disease characterized by recurrent swelling episodes affecting the skin, gastrointestinal mucosa, and upper respiratory tract. Methods: A phase 3, single-arm, open-label study was performed to evaluate a selective bradykinin B2 receptor antagonist...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-04-01
|
| Series: | Allergology International |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893019301571 |